{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:36:30Z","timestamp":1792524990250,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81560688"],"award-info":[{"award-number":["81560688"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81860745"],"award-info":[{"award-number":["81860745"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004880","name":"Xinjiang Medical University","doi-asserted-by":"publisher","award":["230304-10"],"award-info":[{"award-number":["230304-10"]}],"id":[{"id":"10.13039\/501100004880","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bcp.2025.117630","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T01:32:14Z","timestamp":1765416734000},"page":"117630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Cichoriin suppresses hepatic lipid accumulation and fibrosis in mice metabolic dysfunction associated steatohepatitis via the AMPK pathway"],"prefix":"10.1016","volume":"245","author":[{"given":"Yao","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjie","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117630_b0005","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41575-022-00635-5","article-title":"Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight","volume":"19","author":"Eslam","year":"2022","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2025.117630_b0010","doi-asserted-by":"crossref","unstructured":"C.D. Byrne, G. Targher, MASLD, MAFLD, or NAFLD criteria: have we re-created the confusion and acrimony surrounding metabolic syndrome?, Metab. Target Organ Damage 4 (2024) N\/A-N\/A. https:\/\/doi.org\/10.20517\/mtod.2024.06.","DOI":"10.20517\/mtod.2024.06"},{"key":"10.1016\/j.bcp.2025.117630_b0015","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/1878-0261.13685","article-title":"MASH as an emerging cause of hepatocellular carcinoma: current knowledge and future perspectives","volume":"19","author":"Karin","year":"2025","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bcp.2025.117630_b0020","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/HEP.0000000000000822","article-title":"Conserved long noncoding RNA TILAM promotes liver fibrosis through interaction with PML in HSCs","volume":"81","author":"Sun","year":"2025","journal-title":"Hepatol. (baltim. Md,)"},{"key":"10.1016\/j.bcp.2025.117630_b0025","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.cmet.2024.03.011","article-title":"New and emerging treatments for metabolic dysfunction-associated steatohepatitis","volume":"36","author":"Tincopa","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2025.117630_b0030","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2025.117630_b0035","doi-asserted-by":"crossref","DOI":"10.20517\/mtod.2024.54","article-title":"NAFLD to MAFLD: collaboration, not confusion - rethinking the naming of fatty liver disease","author":"Sanal","year":"2024","journal-title":"Metab. Target Organ Damage 4"},{"key":"10.1016\/j.bcp.2025.117630_b0040","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatol. (baltim. Md,)"},{"key":"10.1016\/j.bcp.2025.117630_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113869","article-title":"Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis","volume":"176","author":"Kumar","year":"2021","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/j.bcp.2025.117630_b0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1152\/physrev.00013.2007","article-title":"Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver","volume":"88","author":"Friedman","year":"2008","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2025.117630_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105739","article-title":"Hepatic stellate cells role in the course of metabolic disorders development - a molecular overview","volume":"170","author":"Bourebaba","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2025.117630_b0060","doi-asserted-by":"crossref","first-page":"615","DOI":"10.47162\/RJME.61.3.01","article-title":"Hepatic stellate cells - from past till present: morphology, human markers, human cell lines, behavior in normal and liver pathology","volume":"61","author":"Sufle\u0163el","year":"2020","journal-title":"Rom. J. Morphol. Embryol. = Rev. Roum. Morphol. Embryol."},{"key":"10.1016\/j.bcp.2025.117630_b0065","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cmet.2020.10.026","article-title":"The power of plasticity-metabolic regulation of hepatic stellate cells","volume":"33","author":"Trivedi","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2025.117630_b0070","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41575-023-00846-4","article-title":"Recompensation in cirrhosis: unravelling the evolving natural history of nonalcoholic fatty liver disease","volume":"21","author":"Feng","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2025.117630_b0075","article-title":"Understanding the cellular interactome of non-alcoholic fatty liver disease","volume":"4","author":"Wallace","year":"2022","journal-title":"JHEP Rep.: Innov. Hepatol."},{"key":"10.1016\/j.bcp.2025.117630_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2021.104733","article-title":"TGF-\u03b21 signaling can worsen NAFLD with liver fibrosis backdrop","volume":"124","author":"Ahmed","year":"2022","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bcp.2025.117630_b0085","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41573-019-0019-2","article-title":"AMP-activated protein kinase: the current landscape for drug development","volume":"18","author":"Steinberg","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2025.117630_b0090","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41580-022-00547-x","article-title":"New insights into activation and function of the AMPK","volume":"24","author":"Steinberg","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2025.117630_b0095","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cmet.2017.10.009","article-title":"AMPK: sensing glucose as well as cellular energy status","volume":"27","author":"Lin","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2025.117630_b0100","article-title":"Schisandrin B mitigates hepatic steatosis and promotes fatty acid oxidation by inducing autophagy through AMPK\/mTOR signaling pathway, Metab","volume":"131","author":"Yan","year":"2022","journal-title":"Clin. Exp."},{"key":"10.1016\/j.bcp.2025.117630_b0105","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1126\/science.aay0542","article-title":"An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis","volume":"(n. Y. N.Y.) 367","author":"Zhao","year":"2020","journal-title":"Sci"},{"key":"10.1016\/j.bcp.2025.117630_b0110","doi-asserted-by":"crossref","first-page":"28705","DOI":"10.3390\/ijms161226126","article-title":"Current status of herbal medicines in chronic liver disease therapy: the biological effects, molecular targets and future prospects","volume":"16","author":"Hong","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117630_b0115","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/metabo15010041","article-title":"Ethyl Acetate Extract of Cichorium glandulosum Activates the P21\/Nrf2\/HO-1 Pathway to Alleviate Oxidative stress in a Mouse Model of Alcoholic Liver Disease","volume":"15","author":"Qi","year":"2025","journal-title":"Metabolites"},{"key":"10.1016\/j.bcp.2025.117630_b0120","first-page":"224","article-title":"Chemical constituents and their pharmacological activities of plants from Cichorium genus","volume":"12","author":"Aisa","year":"2020","journal-title":"Chin. Herb. Med."},{"key":"10.1016\/j.bcp.2025.117630_b0125","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.3390\/nu15061322","article-title":"Health benefits of key constituents in cichorium intybus L","volume":"15","author":"Birsa","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.bcp.2025.117630_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2020.127676","article-title":"Chicory (cichorium intybus L.) as a food ingredient - nutritional composition, bioactivity, safety, and health claims: a review","volume":"336","author":"Perovi\u0107","year":"2021","journal-title":"Food Chem."},{"key":"10.1016\/j.bcp.2025.117630_b0135","first-page":"1731","article-title":"Cichoriin, a biocoumarin, mitigates oxidative stress and associated adverse dysfunctions on high-fat diet-induced obesity in rats","volume":"12","author":"Khalil","year":"2022","journal-title":"Life (basel Switz.)"},{"key":"10.1016\/j.bcp.2025.117630_b0140","doi-asserted-by":"crossref","first-page":"7192","DOI":"10.3390\/molecules27217192","article-title":"Mechanistic insights into the ameliorative effect of cichoriin on diabetic rats-assisted with an In silico approach","volume":"27","author":"Khalil","year":"2022","journal-title":"Mol. (basel Switz.)"},{"key":"10.1016\/j.bcp.2025.117630_b0145","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/13813455.2019.1687523","article-title":"DoseCal: a virtual calculator for dosage conversion between human and different animal species","volume":"128","author":"Janhavi","year":"2022","journal-title":"Arch. Physiol. Biochem."},{"key":"10.1016\/j.bcp.2025.117630_b0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2025.117630_b0155","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/17474124.2021.1914587","article-title":"Liver-spleen axis in nonalcoholic fatty liver disease","volume":"15","author":"Tarantino","year":"2021","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2025.117630_b0160","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41575-023-00807-x","article-title":"Hepatic inflammatory responses in liver fibrosis","volume":"20","author":"Hammerich","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2025.117630_b0165","doi-asserted-by":"crossref","DOI":"10.20517\/mtod.2024.39","article-title":"From NAFLD to MAFLD and MASLD: a tale of alcohol, stigma and metabolic dysfunction","author":"Ciardullo","year":"2024","journal-title":"Metab. Target Organ Damage 4"},{"key":"10.1016\/j.bcp.2025.117630_b0170","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/j.2040-4603.2014.tb00548.x","article-title":"Energy metabolism in the liver","volume":"4","author":"Rui","year":"2014","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.bcp.2025.117630_b0175","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-16-0513","article-title":"Hepatic lipid accumulation: cause and consequence of dysregulated glucoregulatory hormones","volume":"234","author":"Geisler","year":"2017","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bcp.2025.117630_b0180","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell. Mol. Life Sci.: CMLS"},{"key":"10.1016\/j.bcp.2025.117630_b0185","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40364-023-00555-9","article-title":"Phenotypic and metabolomic characteristics of mouse models of metabolic associated steatohepatitis","volume":"12","author":"Yang","year":"2024","journal-title":"Biomarker Res."},{"key":"10.1016\/j.bcp.2025.117630_b0190","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ebiom.2018.01.008","article-title":"AMPK Re-activation suppresses hepatic steatosis but its downregulation does not promote fatty liver development","volume":"28","author":"Boudaba","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bcp.2025.117630_b0195","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s10020-023-00721-7","article-title":"Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK\/ACC signaling and inhibiting ferroptosis","volume":"29","author":"Guo","year":"2023","journal-title":"Mol. Med. (camb. Mass,)"},{"key":"10.1016\/j.bcp.2025.117630_b0200","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/hep.31749","article-title":"Cordycepin ameliorates nonalcoholic steatohepatitis by activation of the AMP-activated protein kinase signaling pathway","volume":"74","author":"Lan","year":"2021","journal-title":"Hepatol. (baltim. Md,)"},{"key":"10.1016\/j.bcp.2025.117630_b0205","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.970292","article-title":"The AMPK pathway in fatty liver disease","volume":"13","author":"Fang","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bcp.2025.117630_b0210","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12944-024-02014-2","article-title":"Yam gruel alone and in combination with metformin regulates hepatic lipid metabolism disorders in a diabetic rat model by activating the AMPK\/ACC\/CPT-1 pathway","volume":"23","author":"Dai","year":"2024","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.bcp.2025.117630_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154589","article-title":"Phytochemical gallic acid alleviates nonalcoholic fatty liver disease via AMPK-ACC-PPARa axis through dual regulation of lipid metabolism and mitochondrial function","volume":"109","author":"Zhang","year":"2023","journal-title":"Phytomed.: Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.bcp.2025.117630_b0220","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"MAESTRO-NASH investigators, a phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2025.117630_b0225","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2025.117630_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2025.101487","article-title":"Activation of AMP-activated protein kinase by metformin inhibits dedifferentiation of platelet-derived growth factor-BB-induced vascular smooth muscle cells to improve arterial remodeling in cirrhotic portal hypertension","volume":"19","author":"Wu","year":"2025","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2025.117630_b0235","doi-asserted-by":"crossref","first-page":"d1720","DOI":"10.2741\/pinzani","article-title":"PDGF and signal transduction in hepatic stellate cells","volume":"7","author":"Pinzani","year":"2002","journal-title":"Front. Biosci.: J. Virtual Libr."},{"key":"10.1016\/j.bcp.2025.117630_b0240","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41556-020-0511-2","article-title":"FBP1 loss disrupts liver metabolism and promotes tumorigenesis through a hepatic stellate cell senescence secretome","volume":"22","author":"Li","year":"2020","journal-title":"Nat. Cell Biol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225008950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225008950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T12:15:37Z","timestamp":1781698537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225008950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":48,"alternative-id":["S0006295225008950"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117630","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cichoriin suppresses hepatic lipid accumulation and fibrosis in mice metabolic dysfunction associated steatohepatitis via the AMPK pathway","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117630","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117630"}}